Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice

Medical Science Monitor

Volumn 17, Issue 5, 2011, Pages

  Sedlakova, Miroslava Htoutou ^a   Hanulik, Vojtech ^a   Chroma, Magdalena ^a   Hricova, Kristyna ^a   Kolar, Milan ^a   Latal, Tomas ^a   Schaumann, Reiner ^b   Rodloff, Arne C ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

AmpC; Detection; ESBL; Phenotypic methods

Indexed keywords

BETA LACTAMASE AMPC; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE;

ANALYTIC METHOD; ARTICLE; DIAGNOSTIC TEST; DILUTION; DISK DIFFUSION; DOUBLE DISK SYNERGY TEST; ENTEROBACTERIACEAE; EPSILOMETER TEST; INTERMETHOD COMPARISON; MICROBIOLOGICAL EXAMINATION; MOLECULAR BIOLOGY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

EID: 79955934368     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.881761     Document Type: Article

References (21)

1. Kang CI, Sung HK, Park WB et al: Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumonia. Korean J Intern Med, 2004; 19: 160-65
2. Pai H, Kang CI, Byeon JH et al: Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother, 2004; 48: 3720-28
3. Tumbarello M, Sanguinetti M, Montuori E et al: Predictors of mortality in patients with bloodstream infections caused by extended-spectrumbeta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother, 2007; 51: 1987-94
4. Schwaber MJ, Navon-Venezia S, Kaye KS et al: Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006; 50: 257-62
5. European Antimicrobial Resistance Surveillance System. Available from http://www.rivm.nl/earss. Accessed 10. 1. 2010
6. Paterson DL, Ko WC, Von Gottberg A et al: International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum-beta-lactamase production in nosocomial infections. Ann Intern Med, 2004; 140: 26-32
7. Kolar M, Latal T, Cermak P et al: Prevalence of extended-spectrum-lactamase-positive Klebsiella pneumoniae isolates in the Czech Republic. Int J Antimicrob Ag, 2006; 28: 49-53
8. Livermore DM, Yuan M: Antibiotic resistance and production of extended- spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother, 1996; 38: 409-24
9. Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF: Detection and reporting of organisms producing extended-spectrum b-lactamases: survey of laboratories in Connecticut. J Clin Microbiol, 1999; 37: 4065-70
10. Luzzaro F, Gesu G, Endimiani A et al: Performance in detection and reporting beta-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories. Diagn Microbiol Infect Dis, 2006; 55: 311-18
11. MC, Mata C, Navarro F, Pascual A, the GEMARA collaborative group: Detection and reporting beta-lactam resistance phenotypes in Escherichia coli and Klebsiella pneumoniae: a multicenter proficiency study in Spain. Diagn Microbiol Infect Dis, 2008; 62: 317-25
12. Jarlier V, Nicolas MH, Fournier G, Philippon A: Extended broad-spectrum beta-lactamases conferring transferable resistance to newer b-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis, 1988; 10: 867-78
13. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing, nineteenth informational supplement. 2009; 29(3): M100-S19
14. The European Committee on Antimicrobial Susceptibility Testing. 2009. Available from http://www.eucast.org/clinical_breakpoints. Accessed 15. 4. 2010
15. Yagi T, Wachino J, Kurokawa H et al: Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol, 2005; 43: 2551-58
16. Arlet G, Brami G, Decre D et al: Molecular characterisation by PCRrestriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiol Lett, 1995; 134: 203-8
17. Chanawong A, M'Zali FH, Heritage J et al: Characterisation of extended- spectrum beta-lactamases of the SHV family using a combination of PCR-single strand conformational polymorphism (PCR-SSCP) and PCR-restriction fragment length polymorphism (PCR-RFLP). FEMS Microbiol Lett, 2000; 184: 85-89
18. Pagani L, Dell'Amico E, Migliavacca R et al: Multiple CTX-M-type extended- spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in Northern Italy. J Clin Microbiol, 2003; 41: 4264-69
19. Pérez-Pérez FJ, Hanson ND: Detection of plasmid-mediated AmpC b-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol, 2002; 40: 2153-62
20. Wiegand I, Geiss HK, Mack D et al: Detection of extended-spectrum beta- lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol, 2007; 45: 1167-74
21. Linscott AJ, Brown WJ: Evaluation of four commercially available extended- spectrum beta-lactamase phenotypic confirmation tests. J Clin Microbiol, 2005; 43: 1081-85